Jun 17, 2020
Ascentage Pharma Announces First Patient Dosed in the Phase II Clinical Study of IAP Antagonist APG-1387 in Combination with Entecavir for the Treatment of Patients with Chronic Hepatitis B
Jun 10, 2020
MYR Pharmaceuticals has incorporated its first European subsidiary in France
Jun 05, 2020
Infectious Disease Diagnostics Global Market Estimated to be Worth $24.6 Billion by 2026
May 29, 2020
MYR Pharmaceuticals receives positive CHMP opinion for HEPCLUDEX® (bulevirtide), the First-in-Class Entry Inhibitor for the treatment of chronic hepatitis D infections
Mar 13, 2020
Insights Into the Antiviral Therapeutics Market, 2018-2028 - Featuring 194 Company Profiles and 175 Collaborations
Mar 12, 2020
Non-Opioid Pain Relief Progress Showing Impressive Growth Rate Opportunities
Mar 02, 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Mar 02, 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Feb 12, 2020
Antios Therapeutics Initiates First-in-Human Phase I Study of ATI-2173
Jan 22, 2020
Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody
Nov 12, 2019
Eiger Announces Peginterferon Lambda - Lonafarnib Combination Interim Results in Hepatitis Delta Virus (HDV) Infection from Phase 2 LIFT Study During Late-Breaker Oral Presentation at AASLD 2019
Oct 22, 2019
OrigiMed: The largest cohort study on HBV-Related hepatocellular carcinoma in China released in Cell
Sep 30, 2019
Aridis Pharmaceuticals Executes License Agreement with The Serum Institute of India, Ltd. for Exclusive Rights to Products and Utilization of MabIgX® Platform Technology
Aug 20, 2019
Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection
Aug 14, 2019
Global Antiviral Therapeutics Delivery Research Report 2019: Analysis of Markets, 2018-2019 & Forecasts 2019-2028
Jul 24, 2019
Pennsylvania Biotechnology Center Announces the Launch of Hatch BioFund Management, LLC, a New Investment Arm for Early-Stage Life Sciences Companies
Jun 05, 2019
Eiger Appoints Jeysen Yogaratnam, MB.BCh, BAO, MRCSEd, PhD, MBA, Vice President of Global HDV Clinical Development
Jun 04, 2019
Antiviral Therapeutics Markets, 2028
Apr 30, 2019
Taiwan National Health Insurance Administration of the Ministry of Health and Welfare Approves Vemlidy(R) (tenofovir alafenamide) for Reimbursement
Apr 08, 2019
bioMONTR Labs Announces New Assay for Hepatitis B Pregenomic RNA Quantitation